AOSSM 2023 Annual Meeting Recordings no CME-Panel Discussion: Biologics

Video Transcription

Video Summary

The video discusses the lack of approved stem cell and exosome products in orthopedics. The speaker explains that while there are investigational new drug products being studied, there is no approved product available. The challenges of reproducibly making exosomes and the consequences for clinicians promoting these therapies are also discussed. The video addresses questions about post-op pain strategies without NSAIDs, the use of lidocaine with epi, and the mixture of PRP to Bursa. The speaker expresses the need for further data to understand biologic targets and how to match them with treatment goals. The video concludes with audience questions and the dismissal of the meeting. There are no specific credits given.

Asset Caption

Adam Yanke, MD, PhD; Katherine Coyner, MD; Augustus Mazzocca, MD, MS; Scott Rodeo, MD; Peter Marks, MD, PhD

Keywords

stem cell

exosome

orthopedics

reproducibility

biologic targets